Protagonist Therapeutics Inc - Common Stock (PTGX)
CUSIP: 74366E102
Q3 2023 13F Holders as of 30 Sep 2023
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 63,888,156
- Total 13F shares
- 56,712,373
- Share change
- +73,783
- Total reported value
- $945,896,121
- Put/Call ratio
- 11%
- Price per share
- $16.68
- Number of holders
- 142
- Value change
- -$53,252,231
- Number of buys
- 82
- Number of sells
- 75
Quarterly Holders Quick Answers
What is CUSIP 74366E102?
CUSIP 74366E102 identifies PTGX - Protagonist Therapeutics Inc - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 74366E102:
Top shareholders of PTGX - Protagonist Therapeutics Inc - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP |
13F
|
Company |
8.5%
|
5,415,514
|
$149,576,497 | — | 30 Jun 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
7.8%
|
5,009,273
|
$138,356,122 | — | 30 Jun 2023 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
7.1%
|
4,511,430
|
$124,605,697 | — | 30 Jun 2023 | |
| BVF INC/IL |
13F
|
Company |
5.9%
|
3,775,900
|
$104,290,358 | — | 30 Jun 2023 | |
| STATE STREET CORP |
13F
|
Company |
5.6%
|
3,551,986
|
$98,105,853 | — | 30 Jun 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.9%
|
3,147,755
|
$86,940,993 | — | 30 Jun 2023 | |
| JOHNSON & JOHNSON |
13F
|
Company |
3.8%
|
2,449,183
|
$67,646,434 | — | 30 Jun 2023 | |
| COWEN AND COMPANY, LLC |
13F
|
Company |
2.6%
|
1,657,551
|
$45,781,558 | — | 30 Jun 2023 | |
| Cormorant Asset Management, LP |
13F
|
Company |
2.3%
|
1,500,000
|
$41,430,000 | — | 30 Jun 2023 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
2.3%
|
1,469,761
|
$40,594,799 | — | 30 Jun 2023 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
2%
|
1,292,711
|
$35,704,678 | — | 30 Jun 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.7%
|
1,077,184
|
$29,751,831 | — | 30 Jun 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.6%
|
1,039,105
|
$28,700,427 | — | 30 Jun 2023 | |
| Kynam Capital Management, LP |
13F
|
Company |
1.5%
|
975,298
|
$26,937,731 | — | 30 Jun 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
1.5%
|
935,961
|
$25,851,242 | — | 30 Jun 2023 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
1.3%
|
861,324
|
$23,789,769 | — | 30 Jun 2023 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.3%
|
831,693
|
$22,972,000 | — | 30 Jun 2023 | |
| 683 Capital Management, LLC |
13F
|
Company |
1.3%
|
814,000
|
$22,482,680 | — | 30 Jun 2023 | |
| Holocene Advisors, LP |
13F
|
Company |
1.3%
|
802,531
|
$22,165,906 | — | 30 Jun 2023 | |
| Jefferies Financial Group Inc. |
13F
|
Company |
1.2%
|
760,561
|
$21,006,695 | — | 30 Jun 2023 | |
| S.c.a. Candriam |
13F
|
Individual |
1.1%
|
725,000
|
$20,024,500 | — | 30 Jun 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.9%
|
578,021
|
$15,964,941 | — | 30 Jun 2023 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.88%
|
560,455
|
$15,653,508 | — | 30 Jun 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.88%
|
559,210
|
$15,445,380 | — | 30 Jun 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.86%
|
548,994
|
$15,163,214 | — | 30 Jun 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.84%
|
538,125
|
$14,863,013 | — | 30 Jun 2023 | |
| FMR LLC |
13F
|
Company |
0.79%
|
507,407
|
$14,014,573 | — | 30 Jun 2023 | |
| Artal Group S.A. |
13F
|
Company |
0.78%
|
500,000
|
$13,810,000 | — | 30 Jun 2023 | |
| Woodline Partners LP |
13F
|
Company |
0.67%
|
427,264
|
$11,801,032 | — | 30 Jun 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.66%
|
419,610
|
$11,589,628 | — | 30 Jun 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.65%
|
412,100
|
$11,382,202 | — | 30 Jun 2023 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.63%
|
403,648
|
$11,148,758 | — | 30 Jun 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.61%
|
390,267
|
$10,779,000 | — | 30 Jun 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.59%
|
376,473
|
$10,398,184 | — | 30 Jun 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.55%
|
351,810
|
$9,716,992 | — | 30 Jun 2023 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.5%
|
320,000
|
$8,838,400 | — | 30 Jun 2023 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.49%
|
310,000
|
$8,680,000 | — | 30 Jun 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.46%
|
296,240
|
$8,182,150 | — | 30 Jun 2023 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.45%
|
285,459
|
$7,884,378 | — | 30 Jun 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.41%
|
264,707
|
$7,311,207 | — | 30 Jun 2023 | |
| Invesco Ltd. |
13F
|
Company |
0.41%
|
264,411
|
$7,303,032 | — | 30 Jun 2023 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.35%
|
225,000
|
$6,214,500 | — | 30 Jun 2023 | |
| Gratus Capital, LLC |
13F
|
Company |
0.34%
|
219,586
|
$6,064,966 | — | 30 Jun 2023 | |
| READYSTATE ASSET MANAGEMENT LP |
13F
|
Company |
0.32%
|
204,880
|
$5,658,786 | — | 30 Jun 2023 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.32%
|
202,310
|
$5,587,802 | — | 30 Jun 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.31%
|
199,575
|
$5,512,262 | — | 30 Jun 2023 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.31%
|
195,756
|
$5,407,000 | — | 30 Jun 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0.3%
|
193,439
|
$5,342,785 | — | 30 Jun 2023 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.27%
|
175,529
|
$4,848,110 | — | 30 Jun 2023 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.26%
|
164,500
|
$4,543,489 | — | 30 Jun 2023 |
Institutional Holders of Protagonist Therapeutics Inc - Common Stock (PTGX) as of Q3 2023
As of 30 Sep 2023,
Protagonist Therapeutics Inc - Common Stock (PTGX) was held by
142 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
56,712,373 shares.
The largest 10 holders included
BVF INC/IL, FARALLON CAPITAL MANAGEMENT LLC, RTW INVESTMENTS, LP, BlackRock Inc., STATE STREET CORP, VANGUARD GROUP INC, JOHNSON & JOHNSON, Kynam Capital Management, LP, COWEN AND COMPANY, LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
142
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
163
Q3 2023 holders
142
Holder diff
-21
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 Value $ | Q3 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.